ASRS
ZNTL icon

Arizona State Retirement System’s Zentalis Pharmaceuticals ZNTL Stock Holding History

Arizona State Retirement System’s Portfolio ZNTL Stock Details ZNTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-14,898
Closed -$60.9K – 2167
2024
Q2 		$60.9K Buy
14,898
+1,284
+9% +$14.3K ﹤0.01% 2092
2024
Q1 		$215K Sell
13,614
-204
-1% -$2.81K ﹤0.01% 1890
2023
Q4 		$209K Sell
13,818
-228
-2% -$3.33K ﹤0.01% 1923
2023
Q3 		$282K Buy
14,046
+2,363
+20% +$60K ﹤0.01% 1708
2023
Q2 		$330K Sell
11,683
-1,545
-12% -$37.1K ﹤0.01% 1658
2023
Q1 		$228K Buy
13,228
+365
+3% +$7.39K ﹤0.01% 1868
2022
Q4 		$259K Buy
12,863
+480
+4% +$10.3K ﹤0.01% 1760
2022
Q3 		$268K Buy
12,383
+34
+0.3% +$930 ﹤0.01% 1701
2022
Q2 		$347K Buy
12,349
+6,226
+102% +$165K ﹤0.01% 1583
2022
Q1 		$283K Buy
6,123
+60
+1% +$3.24K ﹤0.01% 1834
2021
Q4 		$510K Buy
6,063
+436
+8% +$33.7K ﹤0.01% 1521
2021
Q3 		$375K Buy
5,627
+107
+2% +$6.17K ﹤0.01% 1701
2021
Q2 		$294K Buy
5,520
+200
+4% +$10.7K ﹤0.01% 1892
2021
Q1 		$231K Buy
5,320
+99
+2% +$4.26K ﹤0.01% 1965
2020
Q4 		$271K Buy
+5,221
New +$236K ﹤0.01% 1786

Other funds holding ZNTL

MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Arizona State Retirement System's ZNTL Position: Q3 2024 in Review

Arizona State Retirement System sold out of Zentalis Pharmaceuticals (ZNTL) in Q3 2024, closing a stake of 14,898 shares — an estimated $60.9K sold.

Arizona State Retirement System first reported a position in ZNTL in Q4 2020 and held it in 15 quarters. The position peaked at $510K in Q4 2021. 136 funds tracked by Wall St. Rank hold ZNTL as of Q3 2024.

  • Arizona State Retirement System reported no remaining Zentalis Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • Arizona State Retirement System sold 14,898 Zentalis Pharmaceuticals shares in Q3 2024, an estimated $60.9K.
  • Arizona State Retirement System first reported a position in Zentalis Pharmaceuticals in Q4 2020 and held it in 15 quarters.
  • Arizona State Retirement System's Zentalis Pharmaceuticals position peaked at $510K in Q4 2021.
  • 136 funds tracked by Wall St. Rank held Zentalis Pharmaceuticals as of Q3 2024.

Based on Arizona State Retirement System's 13F filing for Q3 2024, filed 12 Nov 2024.